Characterization of 5-HT receptors mediating contraction of canine and primate basilar artery by use of GR43175, a selective 5-HT1-like receptor agonist.
about
On serotonin and migraine: a clinical and pharmacological reviewCP-93,129, sumatriptan, dihydroergotamine block c-fos expression within rat trigeminal nucleus caudalis caused by chemical stimulation of the meningesComparative effects of frovatriptan and sumatriptan on coronary and internal carotid vascular haemodynamics in conscious dogsPharmacological evidence for the 5-HT7 receptor mediating smooth muscle relaxation in canine cerebral arteriesCharacterization of 5-HT1D receptor binding sites in post-mortem human brain cortex.One hundred years of migraine research: major clinical and scientific observations from 1910 to 2010.The effect of i.v. sumatriptan, a selective 5-HT1-receptor agonist on central haemodynamics and the coronary circulation.Clinical pharmacokinetics of frovatriptan.Receptor specificity and trigemino-vascular inhibitory actions of a novel 5-HT1B/1D receptor partial agonist, 311C90 (zolmitriptan).Characterization of 5-HT receptors on human pulmonary artery and vein: functional and binding studies.Further characterization of the putative 5-HT receptor which mediates blockade of neurogenic plasma extravasation in rat dura mater.Contractile 5-HT1 receptors in human isolated pial arterioles: correlation with 5-HT1D binding sitesChanges in systolic time intervals-a non-invasive marker for the haemodynamic effects of sumatriptanEffects of sumatriptan on the cerebral intraparenchymal microcirculation in the cat.Comparison of contractile responses to 5-hydroxytryptamine and sumatriptan in human isolated coronary artery: synergy with the thromboxane A2-receptor agonist, U46619Rationale for the use of 5-HT1-like agonists in the treatment of migraine.Serotonin 5-HT1D receptors.Cardiovascular effects from stimulation of 5-hydroxytryptamine receptors.Double-blind, placebo-controlled, dose-finding study of rizatriptan (MK-462) in the acute treatment of migraine.A double-blind, placebo-controlled, crossover, study to evaluate the efficacy of subcutaneous sumatriptan in the treatment of atypical facial pain.Pilot study of MK-462 in migraine.Migraine and cluster headache--their management with sumatriptan: a critical review of the current clinical experience.The 5-HT1-like agonist sumatriptan has a significant effect in chronic tension-type headache.Pre-clinical pharmacology of zolmitriptan (Zomig; formerly 311C90), a centrally and peripherally acting 5HT1B/1D agonist for migraine.Characterization of 5-hydroxytryptamine receptors mediating contractions in basilar arteries from stroke-prone spontaneously hypertensive rats.Presence of vasoconstrictor 5HT1-like receptors revealed by precontraction of rabbit isolated mesenteric artery.Role of 5-HT1-like receptors in the reduction of porcine cranial arteriovenous anastomotic shunting by sumatriptanMediation by 5-HT1D receptors of 5-hydroxytryptamine-induced contractions of rabbit middle and posterior cerebral arteries.Vascular 5-HT1-like receptors mediating vasoconstriction and vasodilatation: their characterization and distribution in the intact canine cardiovascular system.Naratriptan: biological profile in animal models relevant to migraine.5-HT1-like receptors mediate 5-hydroxytryptamine-induced contraction of guinea-pig isolated iliac artery.Vascular 5-HT1-like receptors that mediate contraction of the dog isolated saphenous vein and carotid arterial vasoconstriction in anaesthetized dogs are not of the 5-HT1A or 5-HT1D subtype.Pharmacology of the selective 5-HT(1B/1D) agonist frovatriptan.Effects of dihydroergotamine and sumatriptan on isolated human cerebral and peripheral arteries and veins.5-Hydroxytryptamine-induced vasoconstriction after cerebral hematoma in piglets.Sumatriptan-induced cerebral vasoconstriction as treatment of experimental intracranial hypertension.Effect of sumatriptan, a selective 5-HT1-like receptor agonist, on pial vessel diameter in anaesthetised cats.5-Hydroxytryptamine receptor characterizations of human cerebral, middle meningeal and temporal arteries: regional differencesDifferential Effects of Migraine Drugs on Cerebral Blood Flow Autoregulation
P2860
Q28263827-EEE37927-E4CB-47E4-B679-86F69E473D28Q28326822-A6C11150-993B-4C11-AD1A-D08EA15377D8Q28354207-4CAD2E29-E4E5-4C80-92EA-0D3B45E30B4FQ33867649-E084B1EA-F86D-44E5-82AC-69F60122CCC2Q33920868-8CA49CC6-71BC-4151-A94F-326A9D659B9EQ34180539-31173466-25D6-4202-B74A-AD7A1CCC2E06Q34403370-E049CDFE-8090-4F38-B6B7-014C130EFA6FQ34655551-D12E43FE-7092-4467-B89F-25E865057CF4Q35026033-2B28CCD2-4615-46D0-9A37-B71F8A3AB877Q35026918-989AC23F-4475-4838-9CCC-2033BD882906Q35872010-94F009E0-1F9D-4D6A-848A-7B375A7144E9Q35888605-CBA18BDA-B0B0-4888-BA0D-389317638D3DQ36053732-739FDFC0-E517-4285-8E6B-31B12D636F7EQ36330113-D9B4E8BE-5E06-4B5A-8A69-157B894AF919Q36330430-53F9B692-F060-43C3-B43D-5583326C94BBQ36389341-F179FF6A-192D-4093-B4AF-B040C91E823AQ38004420-CDB1FAD7-392F-482F-95EA-BF703D237DD6Q38680275-7FA78350-8AF3-430E-BC56-72587CE87760Q39452823-9DB063AE-25A0-41FF-88C7-8263A41D20CBQ39462569-F833003A-A381-40FE-91DD-4BD9DA532FA2Q39466431-97E1990C-001C-4165-BCD5-00D38E749B0EQ39471681-F5E5169D-67C4-477B-9351-831D588E389CQ39498342-E2F04DFC-7882-4078-A77C-FD7D844161B5Q41661654-EF554C3C-60B5-49FC-A161-061376D9E7A3Q41899396-E2AC45C2-DA16-49E2-942A-8DA413EF5D68Q41909062-DDBACDFE-F9C7-4405-B393-EFED4E7B5C95Q41970324-3584A9DC-BBED-48BC-91A4-CF19CA2FF2A3Q42015479-F435BF4C-C94B-4379-99B6-9FC04BEEC4F4Q42036074-38EDB6B8-723E-4EC0-AD3E-7B216C0F7348Q42549327-2A0DAA4A-B353-4DBA-9B4D-F23FA172DB78Q42560350-B44ECB66-FB61-4E44-A56F-1EC16780098BQ42561781-B8FCA29D-8AFC-4FFF-B3AD-EB836B28B641Q44004694-E684E684-51EB-4117-91B5-58E9DC9B555DQ48568952-581D86D9-6806-448F-BD4F-48B7BA31F205Q51547468-A2A636E9-D733-4868-969D-DA746771A2DAQ51571431-FE282C1F-D157-42A5-95C0-084C7F23172CQ54271818-E2ADFEE2-0D46-41CC-AAB4-74D4C5744919Q57025099-B196D4CA-5FC1-45D9-AFDD-699BFD3781DAQ57403126-1A6368CD-A759-414D-B11C-80FB2F375F06
P2860
Characterization of 5-HT receptors mediating contraction of canine and primate basilar artery by use of GR43175, a selective 5-HT1-like receptor agonist.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
1989年论文
@zh
1989年论文
@zh-cn
name
Characterization of 5-HT recep ...... e 5-HT1-like receptor agonist.
@ast
Characterization of 5-HT recep ...... e 5-HT1-like receptor agonist.
@en
type
label
Characterization of 5-HT recep ...... e 5-HT1-like receptor agonist.
@ast
Characterization of 5-HT recep ...... e 5-HT1-like receptor agonist.
@en
prefLabel
Characterization of 5-HT recep ...... e 5-HT1-like receptor agonist.
@ast
Characterization of 5-HT recep ...... e 5-HT1-like receptor agonist.
@en
P2093
P2860
P1476
Characterization of 5-HT recep ...... e 5-HT1-like receptor agonist.
@en
P2093
H E Connor
P P Humphrey
P2860
P304
P356
10.1111/J.1476-5381.1989.TB11828.X
P407
P577
1989-02-01T00:00:00Z